Synovex gets $3.5M fundraise, plans clinical trials
Cambridge biotech Synovex Corp., which plans to begin clinical trials this year with a potential treatment for rheumatoid arthritis and fibrotic diseases, has raised the first half of a $7 million round [1], according to federal filings.